Antimicrobials and antimicrobial resistance

Drug discovery and development is becoming increasingly harder due to scientific bottlenecks, increased regulation from approval bodies and economic circumstance. Using unusual approaches to drug discovery can fast-track the production of new antimicrobials, as is the case with drug repurposing. The...

Full description

Bibliographic Details
Main Author: Smith, Frances
Format: Thesis (University of Nottingham only)
Language:English
English
Published: 2017
Subjects:
Online Access:https://eprints.nottingham.ac.uk/48053/
_version_ 1848797679952330752
author Smith, Frances
author_facet Smith, Frances
author_sort Smith, Frances
building Nottingham Research Data Repository
collection Online Access
description Drug discovery and development is becoming increasingly harder due to scientific bottlenecks, increased regulation from approval bodies and economic circumstance. Using unusual approaches to drug discovery can fast-track the production of new antimicrobials, as is the case with drug repurposing. There is a strong need for antimicrobial agents that bacteria can’t develop resistance to and the best way to address this is by developing drugs that do not create a strong selection for resistance. Antivirulence drugs are ideal in this respect as they do not target essential biological processes. It is naïve, however, to assume that bacteria will never develop resistance to any of the antibiotics they are presented with. Careful control over the use of antibiotics should be employed to prevent the development and spread of resistance if we are to avoid the upcoming antibiotic apocalypse.
first_indexed 2025-11-14T20:07:43Z
format Thesis (University of Nottingham only)
id nottingham-48053
institution University of Nottingham Malaysia Campus
institution_category Local University
language English
English
last_indexed 2025-11-14T20:07:43Z
publishDate 2017
recordtype eprints
repository_type Digital Repository
spelling nottingham-480532025-02-28T13:55:17Z https://eprints.nottingham.ac.uk/48053/ Antimicrobials and antimicrobial resistance Smith, Frances Drug discovery and development is becoming increasingly harder due to scientific bottlenecks, increased regulation from approval bodies and economic circumstance. Using unusual approaches to drug discovery can fast-track the production of new antimicrobials, as is the case with drug repurposing. There is a strong need for antimicrobial agents that bacteria can’t develop resistance to and the best way to address this is by developing drugs that do not create a strong selection for resistance. Antivirulence drugs are ideal in this respect as they do not target essential biological processes. It is naïve, however, to assume that bacteria will never develop resistance to any of the antibiotics they are presented with. Careful control over the use of antibiotics should be employed to prevent the development and spread of resistance if we are to avoid the upcoming antibiotic apocalypse. 2017-12-12 Thesis (University of Nottingham only) NonPeerReviewed application/pdf en arr https://eprints.nottingham.ac.uk/48053/1/Smith_Frances_MResThesis_FinalandRevised_Confidential.pdf application/pdf en arr https://eprints.nottingham.ac.uk/48053/2/Smith_Frances_MResThesis_FinalandRevised_ConfidentialRemoved.pdf Smith, Frances (2017) Antimicrobials and antimicrobial resistance. MRes thesis, University of Nottingham. Antimicrobial resistance molecular microbiology drug screening
spellingShingle Antimicrobial resistance
molecular microbiology
drug screening
Smith, Frances
Antimicrobials and antimicrobial resistance
title Antimicrobials and antimicrobial resistance
title_full Antimicrobials and antimicrobial resistance
title_fullStr Antimicrobials and antimicrobial resistance
title_full_unstemmed Antimicrobials and antimicrobial resistance
title_short Antimicrobials and antimicrobial resistance
title_sort antimicrobials and antimicrobial resistance
topic Antimicrobial resistance
molecular microbiology
drug screening
url https://eprints.nottingham.ac.uk/48053/